Cambridge Cognition really exciting position and pipeline of opportunities (Interview)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk to discuss its interim results. Matthew takes us through the highlights, having seen major contract wins across all product families and at all stages of clinical development expands on the company offering, how the company has been impacted by Covid-19 and describes the outlook for COG.

Cambridge Cognition Holdings and its subsidiaries develops and markets digital solutions to assess brain health for sale worldwide, principally in the UK, the US and Europe.

You might also enjoy reading  Cambridge Cognition wins PTSD trials with top 10 pharmaceutical company and US DoD
Find more news, interviews, share price & company profile here for:
Cambridge Cognition Holdings plc

Share this interview

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp